Scott Emily Stella, Lubetkin Erica I, Janssen Mathieu F, Yfantopolous John, Bonsel Gouke J, Haagsma Juanita A
Department of Public Health, Erasmus MC, Rotterdam, Netherlands.
Department of Community Health and Social Medicine, CUNY School of Medicine, New York City, NY, United States.
Front Epidemiol. 2023 May 22;3:1144162. doi: 10.3389/fepid.2023.1144162. eCollection 2023.
Still little is known about the impact of post COVID-19 condition (PC) on health-related quality of life (HRQOL) and mental well-being. We compared participants with PC with three groups: an acute COVID-19 infection (AC) only, at least one chronic condition (CC) but no COVID-19, or no condition at all, healthy (PH). Between these disease groups, we also estimated and compared HRQOL and mental well-being change over time.
Participants from six countries (Greece, Italy, Netherlands, Sweden, United Kingdom and United States) completed two web-based questionnaires (T1 = April-May 2020 and T2 = April-June 2022). Primary outcomes were HRQOL, measured by EQ-5D-5L and EQ VAS, and mental well-being (measured by World Health Organisation-Five (WHO-5) Well-Being Index, Patient Health Questionnaire (PHQ)-9 and General Anxiety Disorder (GAD)-7). All analyses were stratified by the disease groups.
In total, 4,999 participants filled out both surveys: 240 were in PC, 107 in AC, 1798 in CC and 2,854 in PH. At T2, the mean EQ-5D-5L index values for the PC, AC, CC and PH groups were 0.70, 0.73, 0.75 and 0.92 ( < .001), respectively. Mean EQ VAS scores were 66, 65, 68 and 81 ( < .001), respectively. Poor mental well-being, depression and anxiety mean values were highest in the PC group (47.7; 9.1; 7.4), followed by the AC group (51.1; 7.7; 5.7), CC group (56.1; 5.2; 4.2) and the PH group (65.6; 2.8; 2.5), respectively ( < .001 between groups). Over time, HRQOL deteriorated in all groups, apart from the PH group. We observed the largest deterioration in the CC (EQ-5D-5L index: Δ0.03, < .001) and AC group (EQ VAS: Δ6.3, < .001). For the mental well-being outcomes, deterioration for WHO-5 and PHQ-9 were largest in the AC group (Δ4.8, = .016; Δ-1.3, = .012). Rates for GAD-7 improved for the PH and CC groups (PH: Δ1.27, CC: Δ0.56, < .001).
In the cross-sectional analysis, participants with PC had the worst HRQOL and mental well-being compared to the other groups. In terms of change since the start of the COVID-19 pandemic, HRQOL and mental well-being deterioration was highest among AC participants and had a lower impact among PC participants, most likely due to pre-existing chronic disease.
关于新冠后状况(PC)对健康相关生活质量(HRQOL)和心理健康的影响,目前仍知之甚少。我们将患有PC的参与者与三组人群进行了比较:仅患有急性新冠感染(AC)、至少患有一种慢性病(CC)但未感染新冠,或完全没有疾病、健康的人群(PH)。在这些疾病组之间,我们还估计并比较了HRQOL和心理健康随时间的变化。
来自六个国家(希腊、意大利、荷兰、瑞典、英国和美国)的参与者完成了两份基于网络的问卷(T1 = 2020年4月至5月,T2 = 2022年4月至6月)。主要结局指标为通过EQ - 5D - 5L和EQ VAS测量的HRQOL以及心理健康(通过世界卫生组织五福(WHO - 5)幸福指数、患者健康问卷(PHQ) - 9和广泛性焦虑障碍(GAD) - 7进行测量)。所有分析均按疾病组进行分层。
共有4999名参与者完成了两份调查问卷:240人患有PC,107人患有AC,1798人患有CC,2854人健康(PH)。在T2时,PC组、AC组、CC组和PH组的平均EQ - 5D - 5L指数值分别为0.70、0.73、0.75和0.92(P <.001)。平均EQ VAS得分分别为66、65、68和81(P <.001)。心理健康状况不佳、抑郁和焦虑的平均值在PC组中最高(47.7;9.1;7.4),其次是AC组(51.1;7.7;5.7)、CC组(56.1;5.2;4.2)和PH组(65.6;2.8;2.5),组间差异均有统计学意义(P <.001)。随着时间的推移,除PH组外,所有组的HRQOL均有所恶化。我们观察到CC组(EQ - 5D - 5L指数:Δ0.03,P <.001)和AC组(EQ VAS:Δ6.3,P <.001)的恶化最为明显。对于心理健康结局指标,WHO - 5和PHQ - 9在AC组中的恶化最为显著(Δ4.8,P = 0.016;Δ - 1.3,P = 0.012)。PH组和CC组的GAD - 7评分有所改善(PH组:Δ1.27,CC组:Δ0.56,P <.001)。
在横断面分析中,与其他组相比,患有PC的参与者的HRQOL和心理健康状况最差。就自新冠疫情开始以来的变化而言,AC参与者的HRQOL和心理健康恶化程度最高,而PC参与者受到的影响较小,这很可能是由于其先前存在的慢性病所致。